Abstract • 170
We investigated methods to ex vivo expand and activate cord blood (CB) dendritic cells (DC), CB T-cells and peripheral blood (PB) T-cells. Briefly, CB was collected from term vaginal deliveries and MNCs were separated by Ficoll-hypaque (FH) density gradient and adherent cells were resuspended in AIM-V with 10% autologous CB plasma and GM-CSF (100 ng/ml), TNF-α (2.5 ng/ml), Flt3 ligand (25 ng/ml), IL-4 (5 ng/ml) in flasks for 14 d. There was a 22 ± 1.2 fold increase (p<0.01) in cells expressing CD1a+/CD80+/CD86+ and a significant 4.3±0.2 fold reduction in CD14+ cells. Ex vivo expanded DC stimulated allogeneic T-cells by MLR at 1:25 and 1:5 APC to T-cell ratio as measured by MTT proliferation assay (160±13% and 350±50% respectively, p<0.01). CB MNC were isolated by FH then cultured with 5% CB plasma and 5% XLCM™ (kindly provided by Hemosol, Inc. Ontario, Canada). Cell cultures were analyzed and resuspended on days 4, and 7. There was a dramatic 173±58 fold expansion (p<0.05) with an increase cells expressing CD4+/CD25+ (60±6% vs. 0.17±.07%, p<0.0001) and CD8+/CD25+ (33±5% vs. 0%, p<0.0001). Similarly, cytokine activation has been performed with PBMNC which were isolated by FH and non-adherent MNC were cultured in AIM-V serum-free medium with anti-CD3 (50 ng/ml), IL-12 (5-100 U/ml), and IL-2 (5-1000 U/ml) over 10 days with demidepletion on days 4, 7, and 10. On day 7 there was 6.9±0.6 fold expansion of PBMNC, a significant increase in cells expressing CD3+ (98±0.4 vs. 76±2, p<0.05) and CD8+ (71±3% vs. 33±2%, p<0.05). Similarly, there was an increase in MHC Class II expression (39±7 vs. 17±2%, p<0.05), CD45RO+ (61±13 vs. 36±3.4%, p<0.05), and CD25+ (54±12% vs. 0.4±0.1%, p<0.01). Cell culture (IL-2 at 50U/ml) supernatant levels of INF-γ were significantly increased by day 4 to 313±16.7ng/ml vs. 0.1±0.1ng/ml of control (p<0.001), and TNF-α levels were significantly increased to 700±75pg/ml vs. 71±40pg/ml for control (p<0.05). In summary, CB DC can be generated using autologous CB plasma, Flt-3L, GM-CSF, TNF-α, and IL-4, and a significant expansion of CB T-cells can be generated using XLCM™. The combination of anti-CD3, IL-2, and IL-12 significantly expands PB CTL subpopulations and leads to functional activation. Future studies are under way to develop optimal protocols for combining ex vivo expansion of DC and CTL.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cairo, M., Abu-Ghosh, A., Bracho, F. et al. Ex Vivo Expansion and Activation of Cord Blood Antigen Presenting and Immune Effector Cells. Pediatr Res 45 (Suppl 5), 771 (1999). https://doi.org/10.1203/00006450-199905010-00200
Issue Date:
DOI: https://doi.org/10.1203/00006450-199905010-00200